The consensus price target hints at a 25.4% upside potential for Skyward (SKWD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Catalyst (CPRX) points to a 47.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 34.6% in Waystar (WAY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 45.9% in Driven Brands Holdings (DRVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

It's rare to find a company that benefits society and investors. My firm's ability to screen the entire U.S. stock market for the best and worst stocks based on criteria proven to generate alpha makes it uniquely qualified to find such rare companies.

The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Gen Digital (GEN) points to a 30.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 35% upside potential for Slide Insurance Holdings, Inc. (SLDE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound.

The mean of analysts' price targets for Natural Gas Services (NGS) points to a 27.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 64.5% in Nektar (NKTR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for MBX Biosciences, Inc. (MBX) points to an 80.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 27.9% upside potential for Rayonier (RYN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in eToro Group Ltd. (ETOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Beloved Cookie Brand Invites Guests to Enjoy a Free Cookie on Dec. 4 LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Great American Cookies, home of the Original Cookie Cake and owned by FAT (Fresh. Authentic.

Norfolk, Va., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Old Dominion University has announced the establishment of the Joan P. Brock Institute for Nutrition Science and Health to serve as a multidisciplinary hub that integrates sound nutrition and lifestyle medicine into medical and health professions education, basic science and translational research, clinical innovation and community health. This is the second recent transformative gift to advance the academic, health, wellness and research ecosystem in Hampton Roads and beyond following the naming of the Macon & Joan Brock Virginia Health Sciences at Old Dominion University just one year ago.

Regeneron's surge is driven by fresh Eylea HD and Libtayo approvals, even as competition and valuation pressures loom.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.